Conference
The mTOR inhibitor rapamycin (rap) is active against lymphoid leukemia (ALL) in vitro, treats advanced disease in a mouse model, and is antagonized by interleukin-7 (IL-7)
Authors
Brown VI; Barr R; Alcorn K; Rappaport E; Grupp SA
Volume
53
Pagination
pp. 267A-267A
Publisher
INT PEDIATRIC RESEARCH FOUNDATION, INC
Publication Date
April 1, 2003
Name of conference
Annual Meeting of the Pediatric-Academic-Society
Conference place
SEATTLE, WASHINGTON
Conference start date
May 3, 2003
Conference end date
May 6, 2003
Conference proceedings
PEDIATRIC RESEARCH
Issue
4
ISSN
0031-3998